Rwanda launches Africa's first trial of long-acting malaria injection

Reported by 1 outlet · under-reported · first reported Nov 6, 7:23 AM ET

Rwanda began Africa's first clinical trial of a long-acting injectable drug to prevent malaria, a potential shift in prevention.

Why it matters

A single injection could protect people for months.

Malaria kills many African children.

This summary was written automatically from the reporting linked above; follow the sources for the full story. How One Turn works.